Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Minotti

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Chemotherapy|February 12, 2018
Editorial: The Journal Chemotherapy Is for Cardio-Oncologists TooGiorgio Minotti
Blood Advances|May 2, 2024
Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clockGiorgio Minotti
Chemotherapy|May 25, 2021
Quo Vadis COVID? Lessons from a Focus Topic Issue of ChemotherapyGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|July 3, 2013
Pharmacology at work for cardio-oncology: ranolazine to treat early cardiotoxicity induced by antitumor drugsGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2023
All Eyes on Me, Please: Ocular Palonosetron for the Cancer Patient with Nausea and VomitingGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2023
A Special Section on Clinical Pharmacology-EditorialGiorgio Minotti
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
The International Cardioncology Society-ONE trial: Not all that glitters is for cardioncologists onlyGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|February 15, 2024
LDL Cholesterol and Cardiovascular Events in a Population Network: One More Twist of an Endless StoryGiorgio Minotti, Massimiliano Camilli
JACC. Cardiooncology|January 6, 2022
Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black BoxesGiorgio Minotti, Massimiliano Camilli
Cardiovascular Toxicology|July 27, 2007
The anthracyclines: when good things go badGiorgio Minotti, Narine Sarvazyan
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Chemotherapy|February 12, 2018
Editorial: The Journal Chemotherapy Is for Cardio-Oncologists TooGiorgio Minotti
Blood Advances|May 2, 2024
Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clockGiorgio Minotti
Chemotherapy|May 25, 2021
Quo Vadis COVID? Lessons from a Focus Topic Issue of ChemotherapyGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|July 3, 2013
Pharmacology at work for cardio-oncology: ranolazine to treat early cardiotoxicity induced by antitumor drugsGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2023
All Eyes on Me, Please: Ocular Palonosetron for the Cancer Patient with Nausea and VomitingGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2023
A Special Section on Clinical Pharmacology-EditorialGiorgio Minotti
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
The International Cardioncology Society-ONE trial: Not all that glitters is for cardioncologists onlyGiorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|February 15, 2024
LDL Cholesterol and Cardiovascular Events in a Population Network: One More Twist of an Endless StoryGiorgio Minotti, Massimiliano Camilli
JACC. Cardiooncology|January 6, 2022
Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black BoxesGiorgio Minotti, Massimiliano Camilli
Cardiovascular Toxicology|July 27, 2007
The anthracyclines: when good things go badGiorgio Minotti, Narine Sarvazyan
Pageof 13